All filters
Slidesets
Abstract: Correlation between nivolumab exposure and treatment outcome in NSCLC (#O1) | Sander Bins
Presented at:
International Workshop on Clinical Pharmacology of Anticancer Drugs (ICPAD) 2018
Slidesets
Targeted agents and monoclonal antibodies | Joseph Ciccolini, PharmD, PhD
Presented at:
International Workshop on Clinical Pharmacology of Anticancer Drugs (ICPAD) 2018
Slidesets
Cytotoxic agents | Markus Jörger, MD, PhD
Presented at:
International Workshop on Clinical Pharmacology of Anticancer Drugs (ICPAD) 2018
Videos
Targeted agents and monoclonal antibodies | Joseph Ciccolini, PharmD, PhD
Presented at:
International Workshop on Clinical Pharmacology of Anticancer Drugs (ICPAD) 2018
Videos
Cytotoxic agents | Markus Jörger, MD, PhD
Presented at:
International Workshop on Clinical Pharmacology of Anticancer Drugs (ICPAD) 2018
Videos
Rationale for selecting combinations with immunotherapy | Howard Gurney, MBBS, FRACP
Presented at:
International Workshop on Clinical Pharmacology of Anticancer Drugs (ICPAD) 2018
Videos
Immunotherapy of prostate cancer and urothelial cancer. Future directions | Winald Gerritsen
Presented at:
International Workshop on Clinical Pharmacology of Anticancer Drugs (ICPAD) 2018
Videos
Drug-drug interaction management with DDI-Predictor | Michel Tod, PharmD, PhD
Presented at:
International Workshop on Clinical Pharmacology of Anticancer Drugs (ICPAD) 2018
Videos
Pharmacotherapy of Comorbities: Cancer Patients with HIV/AIDS | Michelle Rudek, PharmD, PhD
Presented at:
International Workshop on Clinical Pharmacology of Anticancer Drugs (ICPAD) 2018
Videos
Drug-Drug interactions with targeted oncolytics (in particular PPIs and TKIs) | Ron Mathijssen
Presented at:
International Workshop on Clinical Pharmacology of Anticancer Drugs (ICPAD) 2018
Videos
Clinical relevance of liquid biopsy in cancer patients | Catherine Alix-Panabières, PhD
Presented at:
International Workshop on Clinical Pharmacology of Anticancer Drugs (ICPAD) 2018
Videos
The value of surrogate endpoints in the benefit-risk assessment of new drugs | Gabe Sonke, MD, PhD
Presented at:
International Workshop on Clinical Pharmacology of Anticancer Drugs (ICPAD) 2018
Videos
How studies can be optimized by simultaneous use of PK/PD outcome measurement? | Alwin Huitema
Presented at:
International Workshop on Clinical Pharmacology of Anticancer Drugs (ICPAD) 2018
Meeting
International Conference on (Re-) Emerging Infectious Diseases (ICREID) 2018
12 Mar 2018 - 14 Mar 2018
Addis Ababa , 埃塞俄比亚
Slidesets
General Overview on Emerging Infections globally- Rebecca Martin, PhD
Presented at:
International Conference on (Re-) Emerging Infectious Diseases (ICREID) 2018
Slidesets
Emerging infections on the African continent - The pathogen- John Nkengasong, PhD, MSC
Presented at:
International Conference on (Re-) Emerging Infectious Diseases (ICREID) 2018
Slidesets
Diagnostics for Epidemic Preparedness- Devy Emperador, MPH
Presented at:
International Conference on (Re-) Emerging Infectious Diseases (ICREID) 2018
Slidesets
Ultra-rapid diagnostic testing- Paolo Maggiore
Presented at:
International Conference on (Re-) Emerging Infectious Diseases (ICREID) 2018
Slidesets
Emerging infections on the African continent - The public health response- Ambrose Talisuna, MBchB, Msc, DLSHTM, PhD
Presented at:
International Conference on (Re-) Emerging Infectious Diseases (ICREID) 2018
Slidesets
Fast-tracking vaccines for epidemic diseases: An update from CEPI- Richard Hatchett, MD
Presented at:
International Conference on (Re-) Emerging Infectious Diseases (ICREID) 2018
Slidesets
The role of the human/animal interface in the zoonoses- Jean-Jacques Muyembe, MD, PhD
Presented at:
International Conference on (Re-) Emerging Infectious Diseases (ICREID) 2018
Slidesets
Anti-leishmania donovani antibodies enhance promastigotes internalization into host macrophage (not yet available)- Abdalla Sharief
Presented at:
International Conference on (Re-) Emerging Infectious Diseases (ICREID) 2018